Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Lordick, F. ; Carneiro, F. ; Cascinu, S. ; Fleitas, T. ; Haustermans, K. ; Piessen, G. ; Vogel, A. ; Smyth, E.C.

Elsevier Ltd

Texto completo disponível

Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines

Vogel, A. ; Martinelli, E. ; Vogel, A. ; Cervantes, A. ; Chau, I. ; Daniele, B. ; Llovet, J.M. ; Meyer, T. ; Nault, J.-C. ; Neumann, U. ; Ricke, J. ; Sangro, B. ; Schirmacher, P. ; Verslype, C. ; Zech, C.J. ; Arnold, D. ; Martinelli, E.

England: Elsevier Ltd

Texto completo disponível

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Vogel, A ; Cervantes, A ; Chau, I ; Daniele, B ; Llovet, J M ; Meyer, T ; Nault, J -C ; Neumann, U ; Ricke, J ; Sangro, B ; Schirmacher, P ; Verslype, C ; Zech, C J ; Arnold, D ; Martinelli, E

England: Oxford University Press

Texto completo disponível

Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Vogel, A. ; Bridgewater, J. ; Edeline, J. ; Kelley, R.K. ; Klümpen, H.J. ; Malka, D. ; Primrose, J.N. ; Rimassa, L. ; Stenzinger, A. ; Valle, J.W. ; Ducreux, M.

England: Elsevier Ltd

Texto completo disponível

Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Obermannová, R. ; Alsina, M. ; Cervantes, A. ; Leong, T. ; Lordick, F. ; Nilsson, M. ; van Grieken, N.C.T. ; Vogel, A. ; Smyth, E.C.

Elsevier Ltd

Texto completo disponível

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Vogel, A ; Cervantes, A ; Chau, I ; Daniele, B ; Llovet, J M ; Meyer, T ; Nault, J -C ; Neumann, U ; Ricke, J ; Sangro, B ; Schirmacher, P ; Verslype, C ; Zech, C J ; Arnold, D ; Martinelli, E

Oxford University Press

Texto completo disponível

LBA35 Camrelizumab (C) plus rivoceranib (R) vs. sorafenib (S) as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A randomized, phase III trial

Qin, S. ; Chan, L.S. ; Gu, S. ; Bai, Y. ; Ren, Z. ; Lin, X. ; Chen, Z. ; Jia, W. ; Jin, Y. ; Guo, Y. ; Sultanbaev, A.V. ; Pazgan-Simon, M. ; Pisetska, M. ; Liang, X. ; Chen, C. ; Nie, Z. ; Wang, L. ; Cheng, A-L. ; Kaseb, A. ; Vogel, A.

Texto completo disponível

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS–ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO

Chen, L.-T. ; Martinelli, E. ; Cheng, A.-L. ; Pentheroudakis, G. ; Qin, S. ; Bhattacharyya, G.S. ; Ikeda, M. ; Lim, H.-Y. ; Ho, G.F. ; Choo, S.P. ; Ren, Z. ; Malhotra, H. ; Ueno, M. ; Ryoo, B.-Y. ; Kiang, T.C. ; Tai, D. ; Vogel, A. ; Cervantes, A. ; Lu, S.-N. ; Yen, C.-J. ; Huang, Y.-H. ; Chen, S.-C. ; Hsu, C. ; Shen, Y.-C. ; Tabernero, J. ; Yen, Y. ; Hsu, C.-H. ; Yoshino, T. ; Douillard, J.-Y.

England: Elsevier Ltd

Texto completo disponível

Molecular correlates of response to capmatinib in advanced non-small-cell lung cancer: clinical and biomarker results from a phase I trial

Schuler, M. ; Berardi, R. ; Lim, W.-T. ; de Jonge, M. ; Bauer, T.M. ; Azaro, A. ; Gottfried, M. ; Han, J.-Y. ; Lee, D.H. ; Wollner, M. ; Hong, D.S. ; Vogel, A. ; Delmonte, A. ; Akimov, M. ; Ghebremariam, S. ; Cui, X. ; Nwana, N. ; Giovannini, M. ; Kim, T.M.

England: Elsevier Ltd

Texto completo disponível

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER)

Moehler, M. ; Maderer, A. ; Thuss-Patience, P.C. ; Brenner, B. ; Meiler, J. ; Ettrich, T.J. ; Hofheinz, R.-D. ; Al-Batran, S.E. ; Vogel, A. ; Mueller, L. ; Lutz, M.P. ; Lordick, F. ; Alsina, M. ; Borchert, K. ; Greil, R. ; Eisterer, W. ; Schad, A. ; Slotta-Huspenina, J. ; Van Cutsem, E. ; Lorenzen, S.

England: Elsevier Ltd

Texto completo disponível